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Summary Mechanical stress is an essential factor for physiological response and maintaining
homeostasis of living bodies. Bone changes its molphology and density in response to the physical
circumstances such as mechanical stress. Bone tissue remodeling is regulated by the cells in bone:
osteoblasts, osteoclasts and their progenitors. Recently, osteocytes terminally differentiated from
osteoblasts have been considered to play significant role in bone remodeling and act as mechan-
osensitive cells. We have previously demonstrated that osteocytes early respond to mechanical
compressive force and produce osteopontin to act as mechanotransducers, which induce bone
resorption in the experimental tooth movement model. Meanwhile, we also found that CCN2/CTGF
expression, hereby apoptosis is induced in osteocytes in response to compressive mechanical stress
triggering bone resorption. These results indicate that osteocytes are the major mechanosensitive
cells in bone tissues and involved in regulation of osteoclastic bone resorption. In this review, I would
like to describe the action of compressive mechanical stress in osteocytes and discusse the
molecular and cellular mechanisms of mechanosensing and mechanotransduction leading to the
induction of osteocyte apoptosis and thereafter, to the increase of bone resorption.
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Mechanical stress is an essential factor to maintain home-
ostasis and appropriate physiological responses in living
bodies. Cells are sensitive to their environment, and can
detect both chemical and mechanical signals [1,2]. Essen-
tially all forms of life have the capacity to adapt to physical
signals [3—6], and the cellular machinery responsible for
sensing and responding to mechanical signals might be even
more evolved than those processes regulated by complex
macromolecules [7].
Cells of mesenchymal origin respond to various mechanical
forces to induce proliferation [8,9] and differentiation [9,10]
and to induce pathological or repair mechanisms [11—13].
Numerous cell types, such as vascular endothelial cells [14],
myocytes [15], cardiomyocytes [16], periodontal ligament
cells [17,18], fibroblasts [19], chondrocytes [20,21], and bone
cells [22,23], are thought to have mechanosensitive properties
and play important roles in signal transduction for physiolo-
gical responses. However, in many cells and tissues, the precise
cellular mechanosensors and mechanotransducers are
unknown.
Bone is a dynamic organ, subjected to a variety of mechan-
ical loads during daily activity, and it has the capacity to adapt
structurally in response to mechanical loading [7,24,25].
Mechanical loading is imperative for maintaining bony home-
ostasis, as a lack of mechanical stimulation has been linked to
bone loss in patients with osteoporosis, a highly prevalent and
debilitating disease of aging [26]. Bone tissue remodeling is
regulated by the cells in bone: osteoblasts that produce bone
matrix, osteoclasts that resorb bone, and their respective
progenitor cells [27]. Recently, osteocytes, mature cells that
are terminally differentiated from osteoblasts, have been
considered to act as mechanosensitive cells in the early stage
of bone remodeling [28—30]. However, how the external
loading signal in bone is transmitted at the cellular level,
especially to and between osteocytes, is not well understood,
and the relationship surrounding mechanical stress, cellular
reactions, and bone remodeling is still not fully resolved.
This review describes the in vivo and in vitro evidence
relating connective tissue growth factor (CTGF or CCN2) to
compressive mechanical forces in osteocytes and discussed the
molecular and cellular mechanisms of mechanosensing and
mechanotransduction leading to the induction of osteocyte
apoptosis and, thereafter, to an increase in bone resorption.
2. Osteocytes as mechanosensors and
mechanotransducers in bone
Osteocytes are the most numerous cellular component in
bone tissue, and are embedded in the calcified bone matrix,where they communicate with each other and with osteo-
blasts on the bone surface through slender processes com-
prising gap junctions [31]. Time-lapse imaging of calvarial
explant cultures using transgenic mice with green fluorescent
protein (GFP)-targeted to osteocytes [32] has been used to
observe living osteocytes within their lacunae [33]. Unex-
pectedly, far from being an inactive, quiescent cell type, the
osteocyte was found to be highly dynamic.
In a model of experimental tooth movement, when a force
is loaded to a tooth, there is selective induction of bone
resorption by osteoclasts on the pressured side in the alveolar
bone and bone formation by osteoblasts on the tensioned side
[34]. This differential stress causes the tooth to move in a
specified direction. Using this experimental tooth movement
model, we have previously demonstrated that osteocytes
respond early to mechanical stress and produce osteopontin
(OPN) in its action as a mechanotransducer, suggesting that
osteocytes play a critical role in bone resorption triggered by
mechanical force [28]. Furthermore, Tatsumi et al. [29]
reported that osteocyte-ablated transgenic mice were resis-
tant to tail suspension-induced bone loss. These results
indicated that osteocytes are the major mechanosensitive
cells in bone tissues, and are involved in regulation of
osteoclastic bone resorption and remodeling.
Primary cultures of chick osteocytes in vitro [35] and living
bone ex vivo [36] show that functional gap junctions are
retained between osteocytes and between osteocytes and
osteoblasts. the gap junction connects osteocyte each other
and connects osteocyte and osteoblast to mediate their
intercellular communication.
These findings are consistent with the ability of osteocytes
to respond to and transmit signals over long distances while
embedded apart from each other in a calcified matrix
[35,36]. Gap junctional intercellular communication (GJIC)
is thus thought to play an important role in the integration
and synchronization of bone remodeling. Taken together,
these findings suggest that osteocytes function as mechan-
osensors and/or mechanotransducers, and play crucial roles
in regulating the dynamic nature of bone to mechanical
stimuli.
In addition to OPN, osteocytes produce various factors
such as osteoblast/osteocyte factor 45 (OF45) [37], sclerostin
[38], dentin matrix acidic phosphoprotein (DMP)-1 [39], b-
catenin [40] and receptor activator of nuclear factor-kappaB
ligand (RANKL) [41]. These factors regulate the onset of both
bone formation and resorption, and play pivotal roles in
maintaining bone homeostasis and remodeling in response
to mechanical stimuli. During loading, osteocytes may
experience various forms of mechanical stimuli, such as fluid
flow shear stress, hydrostatic pressure, and direct cellular
deformation by substrate strain, among others [42—44].
These various forms of loading induce biological changes in
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increasing number of studies assessing primary osteocytes
and the osteocyte-like cell line, MLO-Y4 [45] responses to
fluid shear stress [46,47], there is little research concerning
the responses of osteocytes to compressive forces, particu-
larly studies focusing on primary osteocytes in culture. The
MLO-Y4 cell line has thick actin bundles (stress fibers) in the
cell bodies, similar to that observed in primary osteoblasts
[48,49], and they appear to be more sensitive to fluid shear
stress than osteoblast-like cell lines, such as MC3T3-E1 cells,
in calcium response [50]. In comparison, in primary osteo-
cytes, the actin cytoskeleton is localized to the cell processes
and is diffusely distributed throughout the cell body [51],
with a reduced calcium-dependent response to fluid flow
shear stress than that observed with primary osteoblasts
[46]. This differential response to fluid shear stress between
primary osteocytes and MLO-Y4 cells may stem from the
distribution of the actin cytoskeleton.
As such, it might be necessary to investigate physiological
loading responses with primary osteocytes. For this reason,
we previously used primary chicken osteocytes to test com-
pressive strain using our newly established culture system
[52]. This system provides mechanical strain as a single,
quantified degree of compressive force in the culture sub-
strate in the range from 1.2 to 2.9% strain (submitted). This
degree of strain is conventionally thought to be within the
hyperphysiological range of loading. However, the surround-
ing bone matrix is heterogeneous, resulting in magnified local
tissue strain at the level of the osteocytes [53,54]. Recently,
ultra high-voltage electron microscopes were used to analyze
the microstructure of osteocyte cell processes and the sur-
rounding bone matrix [55]. The findings suggested that
osteocytes might have mechanical signal amplification sys-
tems that are mediated via their processes. In fact, in studies
of direct cellular deformation, the degree of strain sensed by
the osteocytes was determined to be larger than that with-
stood during daily activity [56]. Moreover, Jacobs et al. [43]
suggested that habitual strain in bone tissue may not be
consistent between subjects or anatomical sites, and
assumed that an upper limit for bone tissue strain might
be roughly 3%. The application of 2000 microstrain macro-
scopically to a piece of bone resulted in a much greater
microscopic strain surrounding the osteocyte lacunae of over
30,000 microstrain [53]. Taken together, it might be consid-
ered that osteocytes embedded in living bone tissue receive
larger strain as compared with those in bone.
The major cellular components involved in mechanotrans-
duction are integrins, cytoskeletal proteins, GTP-binding reg-
ulatory proteins (G proteins), receptor tyrosine kinases (RTKs),
mitogen-activated protein kinases (MAPKs), and stretch-acti-
vated channels [57]. Signals originating from mechanical sti-
mulation can lead to gene expression and protein synthesis
through the MAPK pathway [57]. Mechanical stretching also
rapidly activates extracellular signal-regulated kinase (ERK)1/
2 in human pulmonary epithelial cells [58]. In addition, p38
MAPK and c-Jun NH2-terminal kinase/stress activated protein
kinase (JNK/SAPK) are activated by various cellular mechan-
ical stresses [57]. Moreover, p38 MAPK, SAPK, and ERK1/2
phosphorylation are activated by compressive loading in the
chondrocytes of articular cartilages [21]. Through these sig-
naling cascades, mechanical compression regulates the activ-
ity of transcriptional factors and gene expression [59].A second route of activation by mechanical stress seems to
be via the NF-kB pathway [60]. Various stresses are known to
induce phosphorylation and degradation of IkB, the cytoplas-
mic inhibitor of the transcription factor NF-kB, which
becomes activated and translocates to the nucleus [60]. This
has been demonstrated to occur in endothelial cells under
shear stress [61]. Activation of NF-kB via protein kinase C-z is
also required for the integrin-dependent ability of fibroblasts
to contract in collagen gels [62].
3. Mechanosensitive genes in the osteocyte
A number of studies have demonstrated load-related
responses in osteocytes in vivo and in vitro, supporting their
proposed roles as mechanotransducers in bone. Changes in
the expression levels of certain genes in osteocytes during
bone modeling and/or remodeling have been investigated,
suggesting complex and interdependent signaling networks
are probably involved in their response to loading.
3.1. Extracellular matrix protein and membrane
protein
CCN2 (also termed connective tissue growth factor, CTGF), is
a 38 kDa, cysteine-rich, extracellular matrix protein that
belongs to the CCN family of proteins. CCN2 has been impli-
cated in numerous cellular events including angiogenesis,
skeletogenesis and wound healing [63]. CCN2 regulates dif-
ferent cellular events, including adhesion, proliferation,
migration, and differentiation [64—67], and it may be an
important growth factor in the control and regulation of
osteogenesis [68,69] possibly in the regulation of mechan-
osensing in osteocytes. However, little is known about the
possible molecular regulation of CCN2 in mechanotransduc-
tion in osteocytes and osteocyte network. The role of CCN2
will be discussed in more detail in later sections.
Additional osteocyte selective markers, such as osteopon-
tin (OPN) [28], dentin matrix protein 1 (DMP1) [70,71],
osteoblast/osteocyte factor 45 (OF45, also called MEPE)
[72] and E11/gp38 [73], are also regulated by mechanical
loading. Among the non-collagenous bone matrix proteins,
OPN was suggested to have a role in bone remodeling by
mediating osteoclast attachment. In support of this, we
found that the expression level of OPN in osteocytes located
in pressure-loaded bone is increased in the process of experi-
mental bone resorption stimulated by mechanical stress
during experimental tooth movement [29]. Studies show that
the DMP1 gene is also activated within a few hours in response
to mechanical loading in osteocytes during the tooth move-
ment model [70]. OF45 [72], a novel, bone-specific extra-
cellular matrix protein, is tightly linked to mineralization and
bone formation. Mouse OF45 is similar to its rat ortholog in
that its expression is increased during mineralization in
osteoblast cultures and within embedded osteocytes. Osteo-
clastogenesis and bone resorption in ex vivo cultures, how-
ever, are unaffected by OF45 mutation in a targeted mouse
line deficient in OF45 [72]. From these results, it was con-
cluded that OF45 plays an inhibitory role in bone formation in
the mouse [72].
E11/gp38, a membrane protein that is osteocyte-selective
and thought to play a role in dendrite elongation, is also
32 T. Takano-Yamamotoactivated within 4 h after a mechanical load, not only in
osteocytes near the bone surface, but also in those deeply
embedded in the bone [73].
3.2. Growth factors and cytokines
Growth factors and cytokines dramatically affect the prolif-
eration and differentiation of cells that express their recep-
tors. Insulin-like growth factor-1 (IGF-1) is a cytokine that
stimulates collagen and DNA synthesis in osteogenic cells and
its action results in an increase in bone formation in vivo [74].
Indeed, one study showed that IGF-1 mRNA expression is
increased in osteocytes of the rat caudal vertebra by mechan-
ical loading within 6 h [75]. Furthermore, the role of IGF-1 in
the translation of mechanical stimuli into bone formation
locally in rat tibiae has been linked to osteocytes [76]. How-
ever, further study is required to understand the role of IGF-1
produced by osteocytes responding to mechanical stress.
The osteocyte-specific marker, sclerostin, is produced by
osteocytes and is the Wnt signaling antagonist encoded by the
Sost gene [77]. Sclerostin is decreased in response to anabolic
loading [78]. In mechanical loading experiments of trans-
genic mice, in which they had been engineered to maintain
high levels of Sost/sclerostin expression, it was found that
the down-regulation of Sost/sclerostin in osteocytes is a
obligatory step in the mechanotransduction cascade that
activates Wnt signaling to direct osteogenesis to where bone
is structurally needed [78]. The Wnt/b-catenin signaling
pathway is regulated largely by proteins that either act as
competitive binding molecules of Wnts, such as the secreted
Frizzled-related protein (sFRP) family, or act at the level of
low-density lipoprotein receptor-related protein (Lrp)-5
[79], such as sclerostin [79], Wise [80] and the Dickkopf
(Dkk) proteins [81—83]. Sclerostin inhibits Wnt/b-catenin
signaling by binding to Lrp5 and preventing the binding of
Wnt in osteoblasts [79]. Taken together, it is suggested that
osteocytes might coordinate the osteogenic response to
mechanical forces by locally unleashing Wnt signaling [78].
As the function of this pathway in the osteocyte is not well
known, further investigation of the Wnt pathway is neces-
sary, particularly in terms of its relationship with bone
responses to mechanical loading.
Receptor activator of nuclear factor-kB ligand (RANKL) is a
multifunctional cytokine expressed by several cell types in
the bone and bone marrow, including osteoblasts, osteo-
cytes, BMSCs and lymphocytes [84—86]. RANKL has been
identified as the membrane-bound factor representing the
osteoclast differentiation factor or the stromal osteoclast-
forming activity expressed by osteoclastogenesis-supporting
cells [84,87]. Recently, it has been reported that osteocytes
express a much higher amount of RANKL [41] and have a
greater capacity to support osteoclastogenesis in vitro than
do osteoblasts and bone marrow stromal cells [88]. Further-
more, the osteocytic cell line, MLO-Y4, expresses RANKL on
their surface and their dendritic processes [87]. The ratio of
RANKL/OPG mRNA is greatest in the MLO-Y4 cells compared
with other cell types. OPG acts as a soluble factor whereas
RANKL is a surface molecule that is functional in osteocyte
bodies or along their exposed dendritic processes [88]. These
results suggest that osteocytes are the most important in vivo
source of RANKL required for osteoclastogenesis. In a recentstudy using mice with a conditional RANKL allele, hindlimb
unloading caused an increase in RANKL mRNA levels in cor-
tical bone [88]. Furthermore, the deletion of RANKL from
DMP1-Cre expressing cells prohibited this cortical bone loss
associated with hindlimb unloading [88]. However, it is
unknown how the elevated levels of RANKL are produced
in osteocytes associated with hind limb unloading.
Interleukin (IL)-33 is a newly identified factor produced by
the osteoblast linage that influences osteoclast formation
[89]. This widely expressed proinflammatory cytokine was
detected in murine osteoblasts and sporadically in osteocytes
[90]. It is suggested that the anti-osteoclastic effect of IL-33 is
not compensated for by other factors in its absence [89,90].
3.3. Glutamate-aspartate transporter (GLAST)
GLASTwas identified as a mechanical stress-responsive gene in
bone by differential RNA display [91]. High levels of GLAST
protein expression were observed localized to osteoblasts and
osteocytes. The GLAST mRNA expression level in osteocytes
was down-regulated in the ulnae that were loaded at 5 Hz for
4 min with a force of 7 N on two occasions during 24 h [91].
GLAST expression was originally found in the central nervous
system, and GLAST plays an important role in neurotransmis-
sion. Since glutamate signaling is involved in bone [92] and
periodontal metabolism [18], the amino acid transporter could
function as a mechanosensing molecule in osteocytes.
3.4. c-fos
Loading-induced changes in the expression of transcription
factors can affect the transcription of multiple downstream
genes. c-fos is a cellular proto-oncogene belonging to the
immediate early response group of transcription factors that
responds to mechanical stress in bone [93] and osteoblasts
[94]. The c-fos gene product acts as a transcription factor,
AP1, by forming a complex with c-JUN; this, in turn, governs
the transcription of numerous downstream genes, including
those involved in differentiation, proliferation [95], and
apoptosis [95]. An increase in c-fos mRNA in osteocytes of
the compressed caudal vertebrae has been demonstrated by
in situ hybridization within 2 h after mechanical loading [75].
3.5. Nitric oxide (NO) and prostaglandins
NO and prostaglandins are two anabolic signals in osteocytes
that are released within seconds in response to mechanical
strain [96]. NO is a short-lived free radical that inhibits
resorption and promotes bone formation [96]. The inhibition
of the nitric oxide synthetase can abolish the loading-induced
increase in prostaglandin E2 [97], and the prostaglandin
inhibitor, indomethacin, can block loading-induced new bone
formation in vivo [98]. These findings suggest that osteocytes
are the primary source of these load-induced prostaglandins
in bone.
3.6. Primary cilia
Primary cilia are solitary, immotile, microtubule-based orga-
nelles that grow from the centrosome and project from the
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bone [100,101]. Single cilia are present on primary bone
cells, and on osteoblastic and osteocytic cell lines. Protein
kinase D (PKD)-1 and PKD2 are components of cilia with
known mechanosensory functions in the kidney that might
also play a role in normal bone structure [101]. Malone et al.
[102] have shown that reducing the number of cilia reduces
the induction of OPN in MC3T3-E1 cells, the induction of
prostaglandin in both MC3T3-E1 and MLO-Y4 cells, and the
increase in COX2 and RANKL/OPG ratio in MLO-Y4 in response
to fluid shear stress.
4. Compressed osteocytes-produced OPN
induces osteoclastic bone resorption
Non-collagenous matrix proteins (NCPs) have multiple func-
tions in bone cells, including the regulation of collagen fibril
mineralization [103] and modulation of cell division, migra-
tion, differentiation and maturation [104]. Among them, OPN,
originally purified from bone, is a sialic acid-rich 44 KD phos-
phorylated glycoprotein that contains an Arg-Gly-Asp (RGD)
adhesion motif [105] and promotes adhesion and spreading of
mesenchymal cells, fibroblasts, and osteoblast-like osteosar-
coma cells. Therefore, OPN is often regarded as a cell attach-
ment factor [105,106], and is thought to promote or regulate
the adhesion, attachment, and spreading of osteoclasts to the
bone surface during bone resorption [107,108]. OPN is pro-
duced by osteoblasts [109—111], as well as osteoclasts
[110,112,113], and is considered to play important roles in
bone formation, resorption, and remodeling [109—116]. It was
found previously that OPN can promote the attachment of
osteoclasts possibly via interaction with the RGDS amino acid
sequence of OPN and avb3 integrin of osteoclasts [107]. We
investigated the spatial gene expression of OPN mRNA in
periodontal ligaments and in the interradicular septum (IRS)
of alveolar bone during physiological tooth movement in rats
[117]. OPN mRNA was detected in osteoclasts and only in
osteocytes located adjacently in the resorption site of the
interradicular septum, strongly suggesting that OPN partici-
pates in bone resorption. The experimental model for ortho-
dontic tooth movement developed by Waldo and Rothblatt
provides further information [28]. Initially, the positive signals
were expressed only in cells located close to the compressed
bone surface of the IRS. After 2 days of treatment, the
expression area spread until almost all of the osteocytes of
the IRS were positive for OPN expression. This suggests a
signaling mechanism caused by mechanical stress that is dis-
persed to surrounding cells, moving from only those at the
distal side (compressed area) to include those cells at the
mesial side (tensioned area of IRS). Following this event,
numerous osteoclasts were recruited to the bone surface
within the entire IRS. The appearance of osteoclasts occurred
with a short delay to the increase in the proportion of OPN
mRNA-positive osteocytes. However, this increase in the num-
ber of OPN mRNA-expressing osteocytes in the IRS was tem-
porary. An in vitro migration assay demonstrated the
chemotactic effect of OPN toward osteoclastic cells, and
results of an in vivo blocking assay using an RGDS peptide
further confirmed this chemotactic role of OPN to stimulate
the migration of osteoclasts to bone surface. The bone surface
of the osteoclast anchoring site is enriched in OPN [116].5. Compressed osteocyte-induced CCN2
triggers osteoclastic bone resorption
CCN2 is a matricellular protein belonging to the CCN family of
secretory proteins that contain 38 conserved cysteine resi-
dues [67]. ‘‘CCN’’ is an acronym for Connective tissue growth
factor (CTGF), Cysteine-rich protein (Cyr61), and Nephro-
blastoma overexpressed gene. There are six members of the
CCN family, namely CCN1 to CCN6: cyr61/cef10, ctgf/fisp12,
nov, elm1/wisp-1, rcop-1/wisp-2, and wisp-3. CCN2, other-
wise known as CTGF, is a ubiquitous 38-KD protein originally
isolated from the culture supernatant of human umbilical
cord venous vascular endothelial cells [118]. CCN2 proteins
have four distinct modules: insulin-like growth factor binding
protein module, Von Willebrand factor module, thrombos-
pondin-homology module and C-terminal cysteine knot mod-
ule (CT module). CCN2 is expressed in a variety of tissues to
promote the proliferation and migration of fibroblasts [66—
69,118]; chemotaxis of embryonic carcinoma cells; and apop-
tosis [119]. Many recent studies have shown that CCN2 is
expressed in normal bones during development, growth, and
remodeling, and that treating osteoblast cultures with
recombinant CCN2 enhances their proliferation and differ-
entiation [69,120,121]. Furthermore, the overexpression of
CCN2 in ST-2 cells, a bone marrow-derived stromal cell line,
increased alkaline phosphatase activity, osteocalcin and
alkaline phosphatase mRNA levels, and mineralized nodule
formation [122]. Taken together, these studies have demon-
strated that CCN2 is expressed in bone tissue and that its
gene product exerts diverse modulatory functions on osteo-
blast differentiation and proliferation.
The CCN2 gene is up-regulated in mechanically challenged
organ systems in response to various etiologies including
hypertension, hemodynamic overload, metabolic injury
and obstruction [123]. Mechanical regulation of the Cyr61/
CCN1 and CTGF/CCN2 proteins has implications in mechan-
ical stress-associated pathologies, with CCN2 gene expres-
sion induced in response to hydrostatic pressure [124],
stretching [125], and shear stress [126] in various cell types.
Exposure of human mesangial cells to hydrostatic pressure for
48 h markedly increased CCN2 protein levels [125]. CCN2
mRNA expression decreased to 25% in 24 h after the load was
removed in human lung fibroblasts [126], while it decreased
to about 13% in vascular endothelial cells after fluid shear
stress for 6 h [127]. Wong et al. [128] compared the effects of
tensile strain and cyclic hydrostatic pressure on CCN2 expres-
sion in primary chondrocytes. Their data indicated that
tensile strain induced CCN2 expression, whereas hydrostatic
pressure had no effect; these findings were in contrast to the
up-regulation of CCN2 in mesangial cells exposed to hydro-
static pressure [125]. These reports suggest that mechanical
stress may induce or inhibit CCN2 expression depending on
the cell type. We performed a continuous application of
mechanical stimulation in vivo using Waldo’s experimental
tooth movement model in rats [129] and in mice [130] for
mechanical-dependent bone remodeling. We found that
CCN2 mRNA expression was markedly increased in osteo-
cytes, especially on the pressured side of alveolar bone
during bone resorption [130]. We showed that the proportion
of CCN2 mRNA-expressing osteocytes significantly increased
within 2 h after the initiation of tooth movement and reached
34 T. Takano-Yamamotoa maximum at 12 h; thereafter, the proportion of CCN2-
expressing osteocytes decreased from days 1 to 21 [130].
Our findings suggest that CCN2 produced during compressive
strain might trigger bone resorption.
Numerous studies concerning the function of CCN2 have
been reported [66—68,131—134] yet not in cultured primary
osteocytes. Understanding the mechanisms whereby
mechanical forces induce CCN2 gene expression is important,
so that mechanotransduction-based therapies and/or phar-
macological intervention can be formulated to prevent/
reverse the deleterious effects of excessive strain and
mechanical overload, as well as mechanical underload, as
found in certain weightlessness conditions [124]. In addition,
while many studies have focused on identifying the candidate
CCN2 receptor, such as lipoprotein receptor-related protein-
1 [135], tyrosine kinase receptor A [136] or integrins
[132,134], the specific receptor for CCN2 has not been
identified.
Integrins are the most important sensors of mechanical
stress, acting as links between the extracellular matrix
proteins and intracellular signaling. It was reported that
integrin avb3 functions as the receptor for the matrix pro-
teins OPN and vitronectin in rat calvarial osteocytes and
enhances mechanotransduction through calcium influx path-
ways [137]. Organization of integrins into focal complexes is
dependent on the type of matrix molecule and is modulated
by the physical state of the matrix [138]. Integrins are
coupled to the actin cytoskeleton via adaptor molecules,
such as integrin-linked kinase, as well as to various signaling
molecules, including MAPKs and the superfamily of small
GTPases [139,140]. For instance, the small GTPases of the
Rho family are central in mechanotransduction, mediating
the formation of focal complexes [141], and transducing
signals that lead to changes in gene expression, cellular
shape and morphology [142].
The CT module in the CCN2 protein interacts with many
types of integrins. Indeed, Nishida et al. [134] reported that
CCN2 interacts with integrin a5b1 in mouse chondrocytes and
activates ERK1/2 signaling. We, too, reported that compres-
sive force could induce ERK1/2 activation in osteocytes
(submitted), and showed that this activation could be pre-
vented by the CCN2 neutralizing antibody, which binds to the
CT module to inhibit its function. We thus speculate that
CCN2 proteins are secreted by osteocytes in response to
compressive loading, where they bind to integrins to activate
ERK1/2.
6. Compressive force-produced CCN2
induces osteocyte apoptosis through MAPKs
Apoptosis is programmed cell death with specific histological
features, such as nuclear condensation and fragmentation. It
differs from cell death caused by necrosis, which is strictly
controlled by cell death-inducing factors [143]. It is an
essential phenomenon for the biological developmental pro-
cess and maintenance of homeostasis [144], but many points
concerning the mechanism and signal transmission involved
in apoptosis remain unclear. There are two major pathways of
apoptosis: (1) death-receptor pathway [144,145] and (2) Bcl-
2-regulated mitochondrial pathway [145,147]. The former
pathway is mediated by death receptors, such as FAS and TNFreceptor and accompanied by caspase-8 activation
[145,146]; the latter pathway is accompanied by caspase-9
activation [147,148].
Osteocyte apoptosis occurs in response to damage-indu-
cing levels of loading [149] or weightlessness [150] and disuse
[47]. Studies report osteocyte apoptosis following mechan-
ical stimulation in the ulnar physical load model [151] and in
the experimental tooth movement model in rats [130,152]. In
addition, Aguirre et al. [153] demonstrated that osteocyte
apoptosis was induced in the murine model of unloading by
tail suspension. We previously reported that apoptosis of
compressive force-loaded osteocytes showed the typical
histological features of nuclear condensation and fragmenta-
tion [130].
Osteocyte apoptosis occurs at sites of microdamage,
where the dying osteocyte may send signals to osteoclasts
for targeted removal of bone [154]. It was found that Bax, an
proapoptotic gene product, was elevated in osteocytes
immediately at the microcrack site, whereas Bcl-2, an
anti-apoptotic gene product, was expressed in cells 1—
2 mm away from the microcrack [154]. This suggests that
damaged osteocytes send signals for bone resorption,
whereas osteocytes not engaged in apoptosis are prevented
from doing so by active protective mechanisms [154]. We
found significant increases in apoptosis-related gene expres-
sion, including caspase-3, -8, -9 and Bcl-2 in osteocytes
during compressive force loading, indicating that both
death-receptor and mitochondrial pathways were activated
in osteocytes under compressive force loading [155]. In
addition, others have reported that osteocyte apoptotic
bodies can initiate osteoclastogenesis [156]. It is still unclear
whether signals of resorption sent by dying osteocytes are the
same as those sent by living osteocytes. Further investigation
is necessary to elucidate the mechanism of the initiation of
bone resorption controlled by osteocytes under compressive
force loading.
CCN proteins induce apoptosis in some cell types
[119,157]. Juric et al. [157] reported that CCN1 and CCN2
synergize with FAS ligand, a TNF family member, to induce
human skin fibroblast apoptosis. In human breast cancer cells
[119] and aortic smooth-muscle cells [158], CTGF/CCN2
induces apoptosis by decreasing Bcl-2 protein expression
and the activation of caspase 3, respectively. In contrast,
CTGF/CCN2 inhibits apoptosis in human rhabdomyosarcoma
cells [159]. However, in osteocytes, it was previously unclear
whether CCN2 induced osteocyte apoptosis. We showed that
in the mouse experimental tooth movement model, CCN2
mRNA expression in osteocytes increased on the pressured
side of alveolar bone, which induced osteocyte apoptosis and
osteoclastic bone resorption [130]. Furthermore, recently we
demonstrated that recombinant human (rh)CCN2 induced
osteocyte apoptosis in primary chick osteocytes in culture
[155]. Thus, we speculate that the enhanced expression of
CCN2 after compressive force loading could be related to
osteocyte apoptosis, which might be an important phenom-
enon in the dynamic responses of these cells to mechanical
stimuli to induce bone resorption.
ERK1/2 activation in cell survival or apoptosis depends
upon the type of cell or stimuli. Park et al. [160] analyzed the
relevance of MAPK activation and reactive oxygen species
(ROS)-induced apoptosis in MC3T3-E1 cells. We also examined
whether MAPKs play a role in osteocytes apoptosis, treating
Osteocyte function under compressive mechanical force 35osteocytes with the ERK1/2 inhibitor, PD98059, and p38 MAPK
inhibitor, SB239063, under compressive force loading [155].
PD98059 significantly blocked loading-induced osteocyte
apoptosis, whereas SB239063 showed a trend, but not sig-
nificant for reduced osteocyte apoptosis. These results indi-
cate that compressive force loading induces osteocyte
apoptosis through activation of MAPK, especially ERK1/2.
However, we did not examine how ERK1/2 activation induces
osteocyte apoptosis, which thus needs to be assessed in
future investigations.
7. Conclusions
Osteocytes produce various factors that mediate the onset
of bone formation and resorption, and play roles in main-
taining bone homeostasis and remodeling in response to
mechanical stimuli. Osteocytes are mechanosensors and
mechanotransducers in bone. As explained in this article,
we have shown previously that osteocytes respond to
mechanical compressive force loaded on the bone with
expression of the osteopontin gene during experimental
tooth movement. Following the increased expression of
OPN in osteocytes, a greater number of osteoclasts and
numerous resorption pits were observed on the pressure
side of the alveolar bone. Furthermore, an in vitro migration
assay demonstrated the chemotactic activity of OPN on the
precursor of osteoclasts. Thus, our study suggests that OPN is
an important migration factor for osteoclast precursor cells
to bone surface, triggering bone resorption caused by
mechanical compressive forces.
In addition to OPN, experimental tooth movement stimu-
lates the gene expression of CCN2/CTGF and induces apop-
tosis in osteocytes in mice. In that study, CTGF mRNA
expression was detected at 2 h in osteocytes on the pressure
side, followed by apoptosis at 6 h after tooth movement in
mice and the number of empty lacunae significantly
increased on day 1 after mechanical stimulation. Thereafter,
the number of osteoclasts significantly increased on the
pressure side of the alveolar bone on day 3. Finally, tooth
movement increased rapidly on day 10. These findings sug-
gest that CTGF expression, followed by apoptosis in osteo-
cytes in response to mechanical compressive force might play
a significant role for bone resorption on pressure side during
tooth movement. CCN2 expression and production were
promoted in isolated osteocytes in vitro under compressive
force loading. The reinforced CCN2 induced osteocyte apop-
tosis through activation of ERK1/2 pathway. These results at
least in part elucidated the mechanism of bone resorption
under mechanical compressive force. Furthermore, we
showed anti-apoptotic effect of CCN2 neutralizing antibody
and ERK1/2 inhibitor, PD98059 in osteocytes under compres-
sive force loading. Exploring therapeutic approaches with
these chemicals will be expected for bone metabolism dis-
order like osteoporosis and bone loss in astronauts or bed-
ridden patients, which are critically related to osteocyte
apoptosis.
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